Utility of large sections (macrosections) in breast cancer pathology

被引:5
作者
Monica, Melissa A. T. [1 ]
Morandi, Luca [1 ]
Foschini, Maria P. [1 ]
机构
[1] Univ Bologna, Bellaria Hosp, Sect Anat Pathol, Dept Biomed & Neuromotor Sci, Bologna, Italy
关键词
Large section (LS); histology; breast cancer; carcinoma in situ; invasive carcinoma; resection margin; tumor extent (TE); tumor multifocality (TM); CARCINOMA IN-SITU; CLINICAL-IMPLICATIONS; DUCTAL CARCINOMA; MULTIFOCALITY; EXTENT; MULTICENTRICITY; RECOMMENDATIONS; SPECIMENS; ANATOMY; DISEASE;
D O I
10.21037/tcr.2017.08.12
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Large sections (LSs), (synomim: macrosections), are used in daily routine practice of breast pathology to better investigate the disease and to allow a thorough diagnosis. It has been demonstrated that costs do not differ from conventional blocking and the turn-around-time could be no longer than 24 hours. Immunohistochemistry or molecular studies are feasible by selecting areas of interest from LS and cutting them to obtain small conventional blocks. LSs are also employed in surgical pathology of various organs, among which breast is comprised. LS in breast pathology is useful to a proper definition of stage disease, tumor size (TS), tumor extent (TE), tumor multifocality (TM) and resection margins. The presence and extension of in situ carcinoma is more completely observed, overcoming the difficulties of gross inspection at naked eye. In the multidisciplinary era, LSs allow the correlations between radiological and pathological data. In addition, LSs play an important role in cases treated with neo-adjuvant (NAD) chemotherapy, as they are useful to better evaluate the residual cancer burden and the degree of tumour regression. The aim of the present paper is to review the value of LS in breast pathology.
引用
收藏
页码:S418 / S423
页数:6
相关论文
共 38 条
[1]   The impact of field cancerization on the extent of duct carcinoma in situ (DCIS) in breast tissue after conservative excision [J].
Asioli, S. ;
Morandi, L. ;
Cavatorta, C. ;
Cucchi, M. C. ;
Foschini, M. P. .
EJSO, 2016, 42 (12) :1806-1813
[2]  
Boros M, 2015, INT J CLIN EXP MED, V8, P9839
[3]   Recommendations for standardized pathological characterization of residual disease for neoadjuvant clinical trials of breast cancer by the BIG-NABCG collaboration [J].
Bossuyt, V. ;
Provenzano, E. ;
Symmans, W. F. ;
Boughey, J. C. ;
Coles, C. ;
Curigliano, G. ;
Dixon, J. M. ;
Esserman, L. J. ;
Fastner, G. ;
Kuehn, T. ;
Peintinger, F. ;
von Minckwitz, G. ;
White, J. ;
Yang, W. ;
Badve, S. ;
Denkert, C. ;
MacGrogan, G. ;
Penault-Llorca, F. ;
Viale, G. ;
Cameron, D. .
ANNALS OF ONCOLOGY, 2015, 26 (07) :1280-1291
[4]  
Cheatle G., 1914, J ROYAL SOC MED, V7, P214
[5]  
Cheatle G L, 1906, Br Med J, V1, P1205
[6]   Cancer of breast - Treatment of the proemial breast [J].
Cheatle, GL .
BRITISH MEDICAL JOURNAL, 1922, 1922 :869-871
[7]  
FAVERLY DRG, 1994, SEMIN DIAGN PATHOL, V11, P193
[8]   The impact of large sections on the study of in situ and invasive duct carcinoma of the breast [J].
Foschini, Maria P. ;
Flamminio, Federica ;
Miglio, Rossella ;
Galo, Daniela G. ;
Cucchi, Maria C. ;
Masetti, Riccardo ;
Eusebi, Vincenzo .
HUMAN PATHOLOGY, 2007, 38 (12) :1736-1743
[9]   The Value of Large Sections in Surgical Pathology [J].
Foschini, Maria P. ;
Baldovini, Chiara ;
Ishikawa, Yuko ;
Eusebi, Vincenzo .
INTERNATIONAL JOURNAL OF BREAST CANCER, 2012, 2012
[10]  
GALLAGER HS, 1969, CANCER, V24, P1170, DOI 10.1002/1097-0142(196912)24:6<1170::AID-CNCR2820240615>3.0.CO